- Home
- CGEN vs DSP Comparison
CGEN vs DSP Comparison
Compare CGEN & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- DSP
- Stock Information
- Founded
- CGEN 1993
- DSP 1999
- Country
- CGEN Israel
- DSP United States
- Employees
- CGEN N/A
- DSP N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- DSP EDP Services
- Sector
- CGEN Health Care
- DSP Technology
- Exchange
- CGEN Nasdaq
- DSP Nasdaq
- Market Cap
- CGEN 125.3M
- DSP 148.7M
- IPO Year
- CGEN 2000
- DSP 2021
- Fundamental
- Price
- CGEN $1.58
- DSP $8.56
- Analyst Decision
- CGEN
- DSP Strong Buy
- Analyst Count
- CGEN 0
- DSP 10
- Target Price
- CGEN N/A
- DSP $19.85
- AVG Volume (30 Days)
- CGEN 522.7K
- DSP 257.8K
- Earning Date
- CGEN 11-10-2025
- DSP 11-10-2025
- Dividend Yield
- CGEN N/A
- DSP N/A
- EPS Growth
- CGEN N/A
- DSP N/A
- EPS
- CGEN N/A
- DSP 0.13
- Revenue
- CGEN $22,144,000.00
- DSP $318,471,000.00
- Revenue This Year
- CGEN N/A
- DSP $16.39
- Revenue Next Year
- CGEN $208.08
- DSP $14.89
- P/E Ratio
- CGEN N/A
- DSP $64.36
- Revenue Growth
- CGEN N/A
- DSP 30.92
- 52 Week Low
- CGEN $1.13
- DSP $8.11
- 52 Week High
- CGEN $2.66
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- CGEN 44.43
- DSP 45.61
- Support Level
- CGEN $1.61
- DSP $8.40
- Resistance Level
- CGEN $1.80
- DSP $9.25
- Average True Range (ATR)
- CGEN 0.11
- DSP 0.41
- MACD
- CGEN -0.03
- DSP 0.03
- Stochastic Oscillator
- CGEN 19.35
- DSP 15.72
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.